Adults

In 1996, nearly a decade before ARVs were publicly available in South Africa, PHRU began providing antiretroviral treatment (ART) by engaging in clinical trial research while actively seeking funding for treatment access programmes. Today, while ARVs are provided through the public sector, South Africa is nonetheless faced with an overburdened public health system and limitations in the availability of and access to drugs. It is because of this that PHRU remains committed to supplementing government efforts while simultaneously searching for new and better ways to treat and care for those living with HIV.

PHRU’s adult clinical trials programme conducts investigator-initiated and pharmaceutical-sponsored trials, and is an accredited clinical research site (CRS) under the AIDS Clinical Trials Group (ACTG). Established as a PEPFAR site in 2004, PHRU has since been able to provide non-study-related HIV treatment and care to thousands of Sowetans, while collecting important data that will inform future treatment strategies.

Clinical Trials and Research

PHRU conducts HIV treatment research in partnership with private pharmaceutical companies, academic and other publicly funded institutions, and as part of the AIDS Clinical Trials Group (ACTG). Learn more about our ongoing clinical trials and research studies.

Services

The PHRU Adult Treatment Access Programme, established in 2004 when ART was not widely accessible in the public health system, provides access to care and antiretroviral treatment for PHRU clients. Today, while ARVs are provided through the public sector, South Africa is nonetheless faced with an overburdened public health system and limitations in the availability of and access to drugs. It is because of this that PHRU remains committed to supplementing government efforts while simultaneously searching for new and better ways to treat and care for those living with HIV.